Literature DB >> 20826830

Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study.

Anna E Prizment1, Andrew Flood, Kristin E Anderson, Aaron R Folsom.   

Abstract

BACKGROUND: We hypothesized that precancer anthropometric variables are associated with mortality among women who developed colon cancer in a prospective cohort, the Iowa Women's Health Study (IWHS).
METHODS: From 1986 to 2005, 1,096 incident cases of colon cancer were identified (mean age at diagnosis, 73 years). Anthropometric characteristics were self-measured before colon cancer diagnosis (in 1986). Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for all-cause and colon-cancer mortality, adjusted for age at cancer diagnosis, stage, education, smoking status, and pack-years of smoking.
RESULTS: During the follow-up of up to 20 years, 493 women died; 289 had colon cancer as the underlying cause. The HRs of all-cause death were increased for the highest versus lowest tertile for weight (HR, 1.39; 95% CI, 1.10-1.76; P trend = 0.005); waist to hip ratio (WHR; HR, 1.36; 95% CI, 1.08-1.72; P trend = 0.008), and waist (HR, 1.45; 95% CI, 1.15-1.82; P trend = 0.001). Compared with that for body mass index (BMI) of 18.5 to 24.9 kg/m(2), HRs were increased for BMI >or=30 kg/m(2) (HR, 1.45; 95% CI, 1.14-1.85) and for the few women with BMI <18.5 kg/m(2) (HR, 1.89; 95% CI, 1.01-3.53). Colon cancer mortality was positively associated with WHR and waist: HR, 1.37 (95% CI, 1.02;1.85; P trend = 0.04) and 1.34 (95% CI, 1.01-1.80; P trend = 0.05), respectively, for the highest versus lowest tertile.
CONCLUSION: Greater precancer anthropometric measures and BMI <18.5 kg/m(2) predicted poorer survival among colon cancer patients. Higher abdominal adiposity measured by WHR and waist was associated with increased risk of colon cancer death. IMPACT: Prediagnostic obesity may be a modifiable risk factor for death in colon cancer patients.

Entities:  

Mesh:

Year:  2010        PMID: 20826830      PMCID: PMC2945249          DOI: 10.1158/1055-9965.EPI-10-0522

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

1.  Survival in colorectal cancer: impact of body mass and exercise.

Authors:  N R Hall
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

2.  Weight-associated deaths in the United States.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  J Womens Health (Larchmt)       Date:  2007-11       Impact factor: 2.681

3.  Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States).

Authors:  V Paul Doria-Rose; Polly A Newcomb; Libby M Morimoto; John M Hampton; Amy Trentham-Dietz
Journal:  Cancer Causes Control       Date:  2006-02       Impact factor: 2.506

4.  Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Authors:  James J Dignam; Kelly Wieand; Karen A Johnson; Peter Raich; Stewart J Anderson; Carol Somkin; D Lawrence Wickerham
Journal:  Breast Cancer Res Treat       Date:  2005-12-06       Impact factor: 4.872

5.  Body-mass index and mortality in Korean men and women.

Authors:  Sun Ha Jee; Jae Woong Sull; Jungyong Park; Sang-Yi Lee; Heechoul Ohrr; Eliseo Guallar; Jonathan M Samet
Journal:  N Engl J Med       Date:  2006-08-22       Impact factor: 91.245

6.  Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.

Authors:  James J Dignam; Blase N Polite; Greg Yothers; Peter Raich; Linda Colangelo; Michael J O'Connell; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

7.  Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies.

Authors:  Susanna C Larsson; Alicja Wolk
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

Review 8.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

9.  Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study.

Authors:  S Zhang; A R Folsom; T A Sellers; L H Kushi; J D Potter
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

10.  Obesity and therapy-related toxicity in patients treated for small-cell lung cancer.

Authors:  M S Georgiadis; S M Steinberg; L A Hankins; D C Ihde; B E Johnson
Journal:  J Natl Cancer Inst       Date:  1995-03-01       Impact factor: 13.506

View more
  33 in total

1.  Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.

Authors:  Ann H Klopp; Yan Zhang; Travis Solley; Felipe Amaya-Manzanares; Frank Marini; Michael Andreeff; Bisrat Debeb; Wendy Woodward; Rosemarie Schmandt; Russell Broaddus; Karen Lu; Mikhail G Kolonin
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

Review 2.  Obesity in cancer survival.

Authors:  Niyati Parekh; Urmila Chandran; Elisa V Bandera
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

3.  Excess body weight and colorectal cancer survival: the multiethnic cohort.

Authors:  Gertraud Maskarinec; Brook E Harmon; Melissa A Little; Nicholas J Ollberding; Laurence N Kolonel; Brian E Henderson; Loic Le Marchand; Lynne R Wilkens
Journal:  Cancer Causes Control       Date:  2015-09-10       Impact factor: 2.506

Review 4.  Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Authors:  Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

5.  Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Authors:  Todd M Gibson; Yikyung Park; Kim Robien; Meredith S Shiels; Amanda Black; Joshua N Sampson; Mark P Purdue; Laura E Beane Freeman; Gabriella Andreotti; Stephanie J Weinstein; Demetrius Albanes; Joseph F Fraumeni; Rochelle E Curtis; Amy Berrington de Gonzalez; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

6.  Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer.

Authors:  Dawn Q Chong; Raaj S Mehta; Mingyang Song; Dmitriy Kedrin; Jeffrey A Meyerhardt; Kimmie Ng; Kana Wu; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-17

7.  Visceral obesity and colorectal cancer: are we missing the boat with BMI?

Authors:  Aaron S Rickles; James C Iannuzzi; Oleg Mironov; Andrew-Paul Deeb; Abhiram Sharma; Fergal J Fleming; John R T Monson
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

8.  Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.

Authors:  Candyce H Kroenke; Romain Neugebauer; Jeffrey Meyerhardt; Carla M Prado; Erin Weltzien; Marilyn L Kwan; Jingjie Xiao; Bette J Caan
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

9.  Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.

Authors:  Whalen Clark; Erin M Siegel; Y Ann Chen; Xiuhua Zhao; Colin M Parsons; Jonathan M Hernandez; Jill Weber; Shalini Thareja; Junsung Choi; David Shibata
Journal:  J Am Coll Surg       Date:  2013-03-21       Impact factor: 6.113

10.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.